Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2131 | ANAB AnaptysBio, Inc. - Common Stock | 57.03 USD | -1.23% | -2.80% | +5.36% | +62.02% | 1.66 B USD | ||
| 2140 | VIR Vir Biotechnology, Inc. - Common Stock | 9.55 USD | -2.35% | +3.24% | +8.28% | +59.70% | 1.62 B USD | ||
| 2143 | ABSI Absci Corporation - Common Stock | 8.96 USD | -6.18% | -1.32% | +15.46% | +243.30% | 1.54 B USD | ||
| 2148 | FBRX Forte Biosciences, Inc. - Common Stock | 76.94 USD | +0.03% | +0.12% | +0.68% | +162.15% | 1.63 B USD | ||
| 2151 | AAPG Ascentage Pharma Group International - American Depository Shar | 16.83 USD | -3.50% | -7.98% | -8.13% | -32.68% | 1.57 B USD | ||
| 2163 | XERS Xeris Biopharma Holdings, Inc. - Common Stock | 8.58 USD | -1.38% | +2.51% | +2.14% | +10.28% | 1.56 B USD | ||
| 2165 | BCAX Bicara Therapeutics Inc. - Common Stock | 23.29 USD | -2.55% | -4.24% | -14.88% | +61.29% | 1.54 B USD | ||
| 2177 | TYRA Tyra Biosciences, Inc. - Common Stock | 25.50 USD | -2.11% | +0.59% | -17.18% | +77.82% | 1.52 B USD | ||
| 2186 | LBRX LB Pharmaceuticals Inc - Common Stock | 47.47 USD | -0.31% | +0.15% | +34.78% | +149.84% | 1.53 B USD | ||
| 2191 | INBX Inhibrx Biosciences, Inc. - Common Stock | 96.27 USD | -7.10% | +8.88% | +16.54% | +19.47% | 1.42 B USD | ||
| 2192 | INVA Innoviva, Inc. - Common Stock | 20.91 USD | -0.76% | -0.85% | -2.74% | +17.34% | 1.51 B USD | ||
| 2204 | NVAX Novavax, Inc. - Common Stock | 8.36 USD | -6.49% | +4.24% | +7.73% | +6.50% | 1.38 B USD | ||
| 2209 | ORIC Oric Pharmaceuticals, Inc. - Common Stock | 13.68 USD | -3.66% | +0.44% | +12.96% | +1.26% | 1.42 B USD | ||
| 2225 | AVBP ArriVent BioPharma, Inc. - Common Stock | 28.77 USD | -1.20% | -1.00% | -9.70% | +39.80% | 1.42 B USD | ||
| 2243 | CGEM Cullinan Therapeutics, Inc. - Common Stock | 21.39 USD | -1.34% | +4.90% | +22.58% | +162.45% | 1.38 B USD | ||
| 2244 | OMER Omeros Corporation - Common Stock | 18.49 USD | -4.05% | +6.76% | +63.63% | +303.71% | 1.34 B USD | ||
| 2245 | REPL Replimune Group, Inc. - Common Stock | 14.25 USD | -3.52% | 0.00% | +63.98% | +152.21% | 1.34 B USD | ||
| 2253 | VOR Vor Biopharma Inc. - Common Stock | 22.14 USD | -5.22% | -1.91% | +14.01% | +69.01% | 1.31 B USD | ||
| 2257 | MGTX MeiraGTx Holdings plc - Ordinary Shares | 13.80 USD | -3.77% | +2.60% | +14.43% | +57.71% | 1.33 B USD | ||
| 2270 | JBIO Jade Biosciences, Inc. - Common Stock | 20.94 USD | -1.87% | -13.86% | +2.35% | +108.36% | 1.33 B USD |
Noticias Biotechnology Stocks
Deutsche Bank rebaja argenx a Mantener por valoración
¿Por qué cae hoy la acción de Monte Rosa Therapeutics?
Las acciones de Biomea Fusion se disparan tras completar el ensayo sobre diabetes
Las acciones de Monte Rosa caen al inicio de un estudio de fase 2 contra el cáncer de próstata
Las acciones de Crinetics Pharmaceuticals alcanzan máximos históricos en 84,8 dólares
H.C. Wainwright reitera su calificación de Biomea Fusion tras inscripción en ensayo
La FDA amplía la revisión de deramiocel de Capricor hasta el 22 de noviembre
Gainers Biotechnology Stocks
SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |